This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2009 Oct 24;374(9699):1396-8.

doi: 10.1016/S0140-6736(09)61600-7. Epub 2009 Sep 11.

Resistant hypertension: an unmet treatment need

Bryan Williams¹

Affiliations

PMID: 19748666
DOI: 10.1016/S0140-6736(09)61600-7

Comment

Resistant hypertension: an unmet treatment need

Bryan Williams. Lancet. 2009.

. 2009 Oct 24;374(9699):1396-8.

doi: 10.1016/S0140-6736(09)61600-7. Epub 2009 Sep 11.

Author

Bryan Williams¹

Affiliation

¹ Department of Cardiovascular Sciences and NIHR Cardiovascular Biomedical Research Unit, University of Leicester, Leicester LE2 7LX, UK. bw17@le.acuk

PMID: 19748666
DOI: 10.1016/S0140-6736(09)61600-7

No abstract available

PubMed Disclaimer

Comment on

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial.
Weber MA, Black H, Bakris G, Krum H, Linas S, Weiss R, Linseman JV, Wiens BL, Warren MS, Lindholm LH. Weber MA, et al. Lancet. 2009 Oct 24;374(9699):1423-31. doi: 10.1016/S0140-6736(09)61500-2. Epub 2009 Sep 11. Lancet. 2009. PMID: 19748665 Clinical Trial.

Similar articles

An endothelin antagonist for resistant hypertension.
Bharti B, Bharti S. Bharti B, et al. Lancet. 2010 Feb 20;375(9715):635; author reply 636-7. doi: 10.1016/S0140-6736(10)60260-7. Lancet. 2010. PMID: 20171391 No abstract available.
An endothelin antagonist for resistant hypertension.
Dhaun N, Goddard J, Webb DJ. Dhaun N, et al. Lancet. 2010 Feb 20;375(9715):635; author reply 636-7. doi: 10.1016/S0140-6736(10)60259-0. Lancet. 2010. PMID: 20171390 No abstract available.
An endothelin antagonist for resistant hypertension.
Naunton M. Naunton M. Lancet. 2010 Feb 20;375(9715):636; author reply 636-7. doi: 10.1016/S0140-6736(10)60262-0. Lancet. 2010. PMID: 20171393 No abstract available.
Darusentan: a new perspective for treatment of resistant hypertension?
Enseleit F, Lüscher TF, Ruschitzka F. Enseleit F, et al. Expert Opin Investig Drugs. 2008 Aug;17(8):1255-63. doi: 10.1517/13543784.17.8.1255. Expert Opin Investig Drugs. 2008. PMID: 18616421 Review.
[Trend of research and development of antihypertensive agents].
Imura Y. Imura Y. Nihon Rinsho. 2006 Jul;64 Suppl 5:583-7. Nihon Rinsho. 2006. PMID: 16895229 Review. Japanese. No abstract available.

See all similar articles

Cited by

Arterial Hypertension-clinical trials update 2023.
Götzinger F, Kunz M, Lauder L, Böhm M, Mahfoud F. Götzinger F, et al. Hypertens Res. 2023 Sep;46(9):2159-2167. doi: 10.1038/s41440-023-01359-y. Epub 2023 Jul 13. Hypertens Res. 2023. PMID: 37443261 Review.
Latest Knowledge on the Role of Vitamin D in Hypertension.
Jensen NS, Wehland M, Wise PM, Grimm D. Jensen NS, et al. Int J Mol Sci. 2023 Feb 28;24(5):4679. doi: 10.3390/ijms24054679. Int J Mol Sci. 2023. PMID: 36902110 Free PMC article. Review.
Clinical efficacy and safety of spironolactone in patients with resistant hypertension: A systematic review and meta-analysis.
Chen C, Zhu XY, Li D, Lin Q, Zhou K. Chen C, et al. Medicine (Baltimore). 2020 Aug 21;99(34):e21694. doi: 10.1097/MD.0000000000021694. Medicine (Baltimore). 2020. PMID: 32846786 Free PMC article.
Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension.
Morimoto S, Ichihara A. Morimoto S, et al. Hypertens Res. 2020 Aug;43(8):744-753. doi: 10.1038/s41440-020-0468-3. Epub 2020 May 18. Hypertens Res. 2020. PMID: 32424201 Review.
The comparative effectiveness of fourth-line drugs in resistant hypertension: An application in electronic health record data.
Sinnott SJ, Smeeth L, Williamson E, Perel P, Nitsch D, Tomlinson LA, Douglas IJ. Sinnott SJ, et al. Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1267-1277. doi: 10.1002/pds.4808. Epub 2019 Jul 16. Pharmacoepidemiol Drug Saf. 2019. PMID: 31313390 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information